{
    "eid": "2-s2.0-85131296713",
    "title": "Respiratory Syncytial Virus, Human Metapneumovirus, and Parainfluenza Virus Infections in Lung Transplant Recipients: A Systematic Review of Outcomes and Treatment Strategies",
    "cover-date": "2022-06-15",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "lung transplantation",
        "paramyxovirus",
        "pneumovirus",
        "ribavirin"
    ],
    "authors": [
        "Auke De Zwart",
        "Annelies Riezebos-Brilman",
        "Gerton Lunter",
        "Judith Vonk",
        "Allan R. Glanville",
        "Jens Gottlieb",
        "Nitipong Permpalung",
        "Huib Kerstjens",
        "Jan Willem Alffenaar",
        "Erik Verschuuren"
    ],
    "citedby-count": 9,
    "ref-count": 42,
    "ref-list": [
        "Disease severity and clinical outcomes of communityacquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network",
        "Community-acquired respiratory viruses in transplant patients: diversity, impact, unmet clinical needs",
        "Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatmenta consensus report from the Pulmonary Council of the ISHLT",
        "Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus",
        "Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin",
        "Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection",
        "Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections",
        "Graft loss and CLAD-Onset is hastened by viral pneumonia after lung transplantation",
        "Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction",
        "Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro",
        "In vitro sensitivity of human parainfluenza 3 clinical isolates to ribavirin, favipiravir and zanamivir",
        "The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration",
        "Testing the reliability and efficiency of the pilot Mixed Methods Appraisal Tool (MMAT) for systematic mixed studies review",
        "Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study",
        "Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation",
        "A single-season prospective study of respiratory viral infections in lung transplant recipients",
        "Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients",
        "Viral respiratory tract infection during the first postoperative year is a risk factor for chronic rejection after lung transplantation",
        "RNA interference therapy in lung transplant patients infected with respiratory syncytial virus",
        "ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients",
        "Community respiratory viral infection in adult lung transplant recipients",
        "The human metapneumovirus: a case series and review of the literature",
        "Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death",
        "Human metapneumovirus and parainfluenza virus infections in lung transplant recipients: the effects on lung allograft and clinical outcomes",
        "Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy",
        "Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients",
        "A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients",
        "Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation",
        "Oral ribavirin for respiratory syncytial virus infection after lung transplantation: efficacy and cost-efficiency",
        "Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study",
        "Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients",
        "DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient",
        "Symptomatic respiratory virus infection and chronic lung allograft dysfunction",
        "CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction",
        "Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection",
        "The epidemiology of parainfluenza virus infection in lung transplant recipients",
        "Oral and inhaled ribavirin treatment for respiratory syncytial virus infection in lung transplant recipients",
        "Clinical outcomes of paramyxovirus infections in lung transplant recipients treated with oral ribavirin: a two-center case series",
        "Human metapneumovirus in lung transplant recipients: characteristics and outcomes",
        "Incidence and outcomes of respiratory viral infections in lung transplant recipients: a prospective study",
        "A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients",
        "Paramyxovirus infection in lung transplant recipients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Sydney",
            "@id": "60010710",
            "affilname": "Faculty of Medicine and Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010710",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Groningen",
            "@id": "60006027",
            "affilname": "Universitair Medisch Centrum Groningen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006027",
            "affiliation-country": "Netherlands"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60025702",
            "affilname": "St. Vincent's Hospital Sydney",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025702",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Hannover",
            "@id": "60024052",
            "affilname": "Hannover Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024052",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60004437",
            "affilname": "Westmead Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004437",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60001117",
            "affilname": "Johns Hopkins School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001117",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hengelo",
            "@id": "114340323",
            "affilname": "Laboratory for Medical Microbiology and Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114340323",
            "affiliation-country": "Netherlands"
        }
    ],
    "funding": []
}